Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
West Allis, WI
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Allis, WI
Click here to add this to my saved trials
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status: Enrolling
Updated:  12/31/1969
Ocular Immunology and Uveitis Foundation
mi
from
Waltham, MA
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status: Enrolling
Updated: 12/31/1969
Ocular Immunology and Uveitis Foundation
mi
from
Waltham, MA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
mi
from
Bakersfield, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
San Diego Retina Associates
mi
from
Oceanside, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
San Diego Retina Associates
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants - Santa Maria
mi
from
Santa Maria, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants - Santa Maria
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern Colorado PC; Clinical Research Department
mi
from
Colorado Springs, CO
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern Colorado PC; Clinical Research Department
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Florida Eye Associates
mi
from
Melbourne, FL
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Florida Eye Associates
mi
from
Melbourne, FL
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
The Retina Institute - Chesterfield
mi
from
Chesterfield, MO
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
The Retina Institute - Chesterfield
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
The Retina Institute
mi
from
Saint Louis, MO
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
The Retina Institute
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Sierra Eye Associates
mi
from
Reno, NV
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Sierra Eye Associates
mi
from
Reno, NV
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Georgia Retina, P.C.
mi
from
Marietta, GA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Georgia Retina, P.C.
mi
from
Marietta, GA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Western Carolina Retinal Associate PA
mi
from
Asheville, NC
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Western Carolina Retinal Associate PA
mi
from
Asheville, NC
Click here to add this to my saved trials
Comparison of Three Soft Bifocal Contact Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Comparison of Three Soft Bifocal Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
North Little Rock, AR
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Blue Springs, MO
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
mi
from
Blue Springs, MO
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Lake Ozark, MO
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
mi
from
Lake Ozark, MO
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Warren, OH
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Warren, OH
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kittanning, PA
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kittanning, PA
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Warwick, RI
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Chamberlain, SD
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
mi
from
Chamberlain, SD
Click here to add this to my saved trials
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Virginia Beach, VA
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated:  12/31/1969
mi
from
Laramie, WY
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated: 12/31/1969
mi
from
Laramie, WY
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
mi
from
Brea, CA
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
mi
from
Brea, CA
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Canoga Park, CA
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Corona, CA
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Corona, CA
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bridgeport, CT
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winter Park, FL
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roswell, GA
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mishawaka, IN
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
mi
from
Blue Springs, MO
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
mi
from
Blue Springs, MO
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Independence, MO
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Independence, MO
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
mi
from
Lake Ozark, MO
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
mi
from
Lake Ozark, MO
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chagrin Falls, OH
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chagrin Falls, OH
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated:  12/31/1969
mi
from
North Olmsted, OH
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
mi
from
North Olmsted, OH
Click here to add this to my saved trials